Global Cell Isolation/Cell Separation Market

Cell Isolation/Cell Separation Market Size, Share, Growth Analysis, By Product(Consumables, Instrument), By Cell Type(Animal Cells, Human Cells), By Technique(Centrifugation, Surface Marker, Filtration), By Cell Source(Bone Marrow, Adipose tissue, Cord blood/Embryonic stem cells), By Application(Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration), By End Use(Research Laboratories & Institutes, Biotechnology & Biopharmaceutical Companies, Hospital & Diagnostic Laboratories, Cell Banks), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2169 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 173 | Figures: 71

Cell Isolation/Cell Separation Market Competitive Landscape

Global Cell Isolation/Cell Separation Market is competitive and fragmented. Key players include Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Danaher, Beckman Coulter, Inc. and Cytiva. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market.

 Cell Isolation/Cell Separation Market Top Player's Company Profiles

Cell Isolation/Cell Separation Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cell Isolation/Cell Separation Market size was valued at USD 2.1 billion in 2019 and is poised to grow from USD 3.2 billion in 2023 to USD 11.6 billion by 2031, growing at a CAGR of 21.8% in the forecast period (2024-2031).

In October 2022, the world's leading provider of scientific services, Thermo Fisher Scientific Inc., unveiled the GibcoTM CTSTM DynaCellectTM Magnetic Separation System (DynaCellect) to make it simple for companies developing cell therapies to transition from process and clinical development to commercial manufacturing. A scalable, adaptable, automated, closed system is provided by this next-generation cell separation, cell activation, cell depletion, and DynabeadsTM magnetic beads removal apparatus to help optimize the cell therapy manufacturing process. 'Terumo Corporation', 'STEMCELL Technologies Inc.', 'Bio-Rad Laboratories, Inc.', 'Merck KGaA', 'GE Healthcare', 'Miltenyi Biotec', 'pluriSelect Life Science UG & Co. KG', 'Takara Bio Inc', 'EMD Millipore', 'PerkinElmer', 'ZEISS', 'Akadeum Life Sciences'

The primary driver for market expansion is the rise in number of cancer infected patients. The market is also anticipated to develop as a result of rise in government support for cell-based research, and a growing emphasis on customised treatment, and technical advancements. 

Growing use of microfluidic technologies: The use of microfluidic technologies offers a better control for cell flows and fluids resulting in an effective cell separation.

North America accounted for a large market share in 2022. This can be ascribed to the developed pharmaceutical and biotech sectors as well as the widespread use of innovative technology in the United States. There is a big market for cell separation technologies as a result of research universities' extensive activity in the field of cell treatments. Additionally, the growing incidence of chronic and infectious disorders, has increased the need for cell separation technologies for use in both research and therapeutic settings.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cell Isolation/Cell Separation Market

Report ID: SQMIG35H2169

$5,300
BUY NOW GET FREE SAMPLE